Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
Screening for Hepatitis C Improves Opioid Abuse Treatment Outcomes

Research presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

Published
11 hours ago
From
AASLD
Hepatitis C cure leads to improved quality of life

People who were cured of hepatitis C with direct-acting antivirals (DAAs) had sustained improvements in their health-related quality of life, including both physical and mental

Published
11 hours ago
By
Liz Highleyman
Restrictions on free DAA access in many European countries contrary to guidelines and undermine HCV elimination targets, say researchers

The restrictions which many European countries impose on free/reimbursed access to hepatitis C virus (HCV) direct-acting antivirals (DAAs) are contrary to guidelines and undermine the

Published
17 October 2017
By
Michael Carter
Egypt launches aggressive campaign to stamp out hepatitis C

Egypt has the highest rate of hepatitis C in the world. Now the country has undertaken an aggressive campaign to stamp out the disease, both domestically and abroad.

Published
06 October 2017
From
FRANCE 24
Hep C: An end in sight?

Despite its prevalence, hepatitis C has long been under-prioritised by health services. But could new drugs and a new commitment from the NHS mean we may finally see this killer condition eradicated?

Published
05 October 2017
From
Drink & Drug News
The Hepatitis Drug Market Is Worse Than Wall Street Realises

Slowing hepatitis C drug sales have taken a bite out of Gilead's share price.This is a smart retreat for Merck and J&J. The HCV market is well past its peak. Both of their new therapies would have been very late; AbbVie and Gilead both had new drugs approved this year. Their best hope likely would have been to compete on price in a market that's been warring over price for a while.

Published
04 October 2017
From
Bloomberg
VA models provide guidance for care of hepatitis C infection

The U.S. Department of Veterans Affairs (VA) has developed models of care that can be used to reduce the overall burden of hepatitis C virus (HCV) infection, according to a study published online Sept. 25 in the Annals of Internal Medicine.

Published
28 September 2017
From
Medical Xpress
No, there isn’t a hepatitis cure ‘for hipsters’ with a £35,000 price tag and own clothing line

A new hepatitis C drug costing ‘just’ £2,000-a-month for 18 months (£36,000) was ‘launched’ on the web with a fancy video and young people showing off the new ‘exclusive’ drug to cure hepatitis C.

Published
27 September 2017
From
Metro
High prices of DAAs mean there's been little progress towards achieving WHO target of eliminating HCV by 2030

Only a handful of countries are on course to achieve the World Health Organization (WHO) target of eliminating hepatitis C virus (HCV) as a major

Published
15 September 2017
By
Michael Carter
Injection drug users with HCV in Scotland lack awareness of DAA efficacy

Most people who inject drugs were not aware of currently available, highly effective hepatitis C treatments, according results of a national survey in Scotland presented at the International Symposium on Hepatitis Care in Substance Users. Researchers asked, “What are the chances of hepatitis C being cured with current treatment?” Most participants responded that the chance was low or less than 40%.

Published
12 September 2017
From
Healio
← First12345...94Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.